HC Wainwright & Co. Maintains Buy on AnaptysBio, Lowers Price Target to $52
HC Wainwright & Co. Maintains Buy on AnaptysBio, Lowers Price Target to $52
HC Wainwright公司繼續買入anaptysbio股票,將目標價調低至$52
HC Wainwright & Co. analyst Emily Bodnar maintains AnaptysBio (NASDAQ:ANAB) with a Buy and lowers the price target from $55 to $52.
HC Wainwright分析師Emily Bodnar維持anaptysbio(納斯達克:ANAB)買入評級,將目標股價從55美元降至52美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。